Interestingly, the expression of ERα, PR, and HER2 in primary breast cancer cells was concordant with the expression of molecular markers in the counterpart breast cancer tissues (see Figures 2A, B and Table 2). The gene discussed is ERBB2; the disease is breast carcinoma.